Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
ABJM Wilson loops in arbitrary representations
ABJM amplitudes and WL at finite N
ABJM membrane instanton from a pole cancellation mechanism
ABJM amplitudes in U-gauge and a soft theorem
ABJM on ellipsoid and topological strings
ABJM baryon stability and Myers effect
ABJM theory as a Fermi gas
ABJM with flavors and FQHE
ABJM dibaryon spectroscopy
ABJM theory with mass and FI deformations and quantum phase transitions
ABJS Carl T. Brighton Workshop on Health Informatics in Orthopaedic Surgery: Editorial Comment
ABJS Carl T. Brighton Workshop on Hip Preservation Surgery
ABL Regulation by AXL Promotes Cisplatin Resistance in Esophageal Cancer
ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases
ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling
ABL kinase inhibitory and antiproliferative activity of novel picolinamide based benzothiazoles
ABL SH3-T79Y突变体联合伊马替尼对慢性粒细胞白血病细胞增殖的影响
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia
ABL Tyrosine Kinase Inhibition Variable Effects on the Invasive Properties of Different Triple Negative Breast Cancer Cell Lines
ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1
ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia in Jordan
ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell
ABL AT THE LEADING EDGE
ABL to Integrate Opposing Cellular Growth Signals
ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method
ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-Jun NH2-terminal kinase activation
ABL-N may induce apoptosis of human prostate cancer cells through suppression of KLF5, ICAM-1 and Stat5b, and upregulation of Bax/Bcl-2 ratio: An in vitro and in vivo study
ABL1 gene involvement within a complex three-way translocation (2;9;4) in perineurioma characterized by molecular cytogenetic methods
ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review
ABL1相关融合基因与急性淋巴细胞性白血病关系的研究进展
ABL1 fusion genes in hematological malignancies: a review
ABL1 regulates spindle orientation in adherent cells and mammalian skin
ABL1 Joins the Cadre of Spindle Orientation Machinery
ABL1 deletion without BCR/ABL1 rearrangement is originated from a large-sized 9q deletion
ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells
ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
ABL800血气分析仪与BC5800血细胞分析仪检测HGB与HCT结果的比较研究
ABLATION PROPERTY OF SiC-TaSi2 COATED CARBON/CARBON COMPOSITES
ABLATIVE HELE-SHAW MODEL FOR ICF FLOWS MODELING AND NUMERICAL SIMULATION
ABLATION OF LEIOMYOMAS USING A COMBINATION OF HIFU AND IODIZED OIL IN VITRO
ABLATION OF FAST-SPIKING INTERNEURONS IN THE DORSAL STRIATUM, RECAPITULATING ABNORMALITIES SEEN POST-MORTEM IN TOURETTE SYNDROME, PRODUCES ANXIETY AND ELEVATED GROOMING
ABLATIVE TECHNIQUES: RADIOFREQUENCY AND CRYOTHERAPY, WHICH IS THE BEST?
ABLATION OF TNF-alpha RECEPTORS INFLUENCES MESENCHYMAL STEM CELL-MEDIATED CARDIAC PROTECTION AGAINST ISCHEMIA
ABLATION OF ICE-CORED MORAINE IN A HUMID, MARITIME CLIMATE: FOX GLACIER, NEW ZEALAND
ABLATION AND CHEMICAL ALTERATION OF COSMIC DUST PARTICLES DURING ENTRY INTO THE EARTH%26apos;S ATMOSPHERE
ABLATION BEHAVIOUR AND MICROSTRUCTURE OF CARBON/CARBON AND HYBRID CARBON/CARBON COMPOSITES BASED ON PLASMA TORCH HEATING
ABLE: A New and Improved Amphotericin B for Visceral Leishmaniasis?
ABLE: a standing style transfer system for a person with disabled lower limbs (improvement of stability when traveling)
ABLI Rearrangements in T-Cell Acute Lymphoblastic Leukemia
ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1
ABLUE—一种新的自适应主动队列管理方法
ABL沉默对DOX和TRAIL诱导结肠癌细胞HT29凋亡的影响
ABL教学法及其对思想政治理论课实践教学的启示
ABM Clinical Protocol #2: Guidelines for Hospital Discharge of the Breastfeeding Term Newborn and Mother: "The Going Home Protocol,'' Revised 2014
ABM Clinical Protocol #18: Guidelines for Breastfeeding Infants with Cleft Lip, Cleft Palate, or Cleft Lip and Palate, Revised 2013
ABM Clinical Protocol #4: Mastitis, Revised March 2014
ABM Clinical Protocol #26: Persistent Pain with Breastfeeding
ABM Position on Breastfeeding-Revised 2015
ABM Clinical Protocol #21: Guidelines for Breastfeeding and Substance Use or Substance Use Disorder, Revised 2015
ABM Clinical Protocol # 19: Breastfeeding Promotion in the Prenatal Setting, Revision 2015
ABM Clinical Protocol #23: Nonpharmacological Management of Procedure-Related Pain in the Breastfeeding Infant, Revised 2016
ABM Clinical Protocol #20: Engorgement, Revised 2016
ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting the Rate of Maternal Milk Secretion (First Revision January 2011) The Academy of Breastfeeding Medicine Protocol Committee
ABM Clinical Protocol #13: Contraception During Breastfeeding, Revised 2015
ABM Clinical Protocol #14: Breastfeeding-Friendly Physician%26apos;s Office: Optimizing Care for Infants and Children, Revised 2013
ABM Clinical Protocol #7: Model Breastfeeding Policy (Revision 2010)
ABM Clinical Protocol #5: Peripartum Breastfeeding Management for the Healthy Mother and Infant at Term, Revision 2013
ABM Clinical Protocol #10: Breastfeeding the Late Preterm Infant (34(0/7) to 36(6/7) Weeks Gestation) (First Revision June 2011)
ABM Clinical Protocol #4: Mastitis
ABM Clinical Protocol #24: Allergic Proctocolitis in the Exclusively Breastfed Infant
ABM Clinical Protocol #25: Recommendations for Preprocedural Fasting for the Breastfed Infant: "NPO" Guidelines The Academy of Breastfeeding Medicine
ABM Clinical Protocol #23: Non-Pharmacologic Management of Procedure-Related Pain in the Breastfeeding Infant The Academy of Breastfeeding Medicine Protocol Committee
ABM Clinical Protocol #3: Hospital Guidelines for the Use of Supplementary Feedings in the Healthy Term Breastfed Neonate, Revised 2009
ABM Clinical Protocol #1: Guidelines for Blood Glucose Monitoring and Treatment of Hypoglycemia in Term and Late-Preterm Neonates, Revised 2014
ABM Clinical Protocol #8: Human Milk Storage Information for Home Use for Full-Term Infants (Original Protocol March 2004; Revision #1 March 2010)
ABM Clinical Protocol # 3: Supplementary Feedings in the Healthy Term Breastfed Neonate, Revised 2017
ABM Clinical Protocol #27: Breastfeeding an Infant or Young Child with Insulin-Dependent Diabetes
ABM Clinical Protocol #18: Use of Antidepressants in Breastfeeding Mothers
ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017
ABM Clinical Protocol #8: Human Milk Storage Information for Home Use for Full-Term Infants, Revised 2017
ABM Clinical Protocol #10: Breastfeeding the Late Preterm (34-36 6/7 Weeks of Gestation) and Early Term Infants (37-38 6/7 Weeks of Gestation), Second Revision 2016